Nebraska Judiciary Committee Votes to Legalize Medical Marijuana

Nebraska’s Judiciary Committee has passed legislation to legalize medical marijuana.

Legislative Bill 622 was passed by the Judiciary Committee with a 6 to 1 vote, with Senator Stebe Halloran casting the sole “No” vote. The measure allows those with a qualifying condition to possess and use marijuana medicines if they receive a recommendation from a physician and become licensed with the state. A system of regulated marijuana dispensaries would be authorized.

Qualifying conditions would include opioid addiction, AIDS, epilepsy, glaucoma, Crohn’s disease, Tourette’s syndrome, hepatitis C, lupus, Parkinson’s disease, Lyme disease, spinal cord injury or disease, post traumatic stress disorder (PTSD) and anxiety.

Read moreNebraska Judiciary Committee Votes to Legalize Medical Marijuana

Study: Psychedelic Drugs May Treat Anxiety, Addiction and Post Traumatic Stress Disorder

A psilocybin, or "magic", mushroom.
A psilocybin, or “magic”, mushroom.

By Alan Mozes, HealthDay Reporter

In a carefully controlled setting, psychedelic drugs such as LSD or “magic mushrooms” may benefit patients with hard-to-treat anxiety, addiction or post-traumatic stress disorder (PTSD), new research suggests.

The finding comes from a review of small-scale and preliminary studies conducted recently in the United States, Canada and Europe, all of which await follow-up.

These preliminary results show that “in the right context, these drugs can help people a lot, especially people who have disorders that we generally treat poorly, such as end-of-life distress, PTSD, and addiction issues involving tobacco or alcohol,” said study co-author Matthew Johnson. Johnson is an associate professor in the department of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine in Baltimore.

Read moreStudy: Psychedelic Drugs May Treat Anxiety, Addiction and Post Traumatic Stress Disorder

Illinois State Board Recommends Migraines, PTSD and Other Ailments As Medical Cannabis Conditions

The illinoismedicalIllinois Medical Cannabis Advisory Board on Monday voted to recommend a variety of medical ailments as conditions that qualify an individual to become a legal medical cannabis patient.

The Board voted 8 to 2 to recommend to the Illinois Department of Health that migraines be added as qualifying conditions for medical cannabis use. The panel voted unanimously to recommend irritable bowel syndrome, post traumatic stress disorder, periphery polyneuropathy and diabetic neuropathy, and voted 7 to 4 to recommend osteoarthritis.

Read moreIllinois State Board Recommends Migraines, PTSD and Other Ailments As Medical Cannabis Conditions

New Study: LSD Reduces Anxiety In Those With Terminal Illnesses

New data published online by the Journal of Nervous and Mental Disease has found that LSDlsd therapy can significantly reduce anxiety in those who have life-threatening diseases. This is the first controlled trial data on LSD to be released in more than 40 years.

“A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases”, claims the study’s author Dr. Peter Gasser.

Read moreNew Study: LSD Reduces Anxiety In Those With Terminal Illnesses